ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.145
-0.065 (-2.94%)
At close: Mar 9, 2026, 4:00 PM EDT
2.130
-0.015 (-0.70%)
After-hours: Mar 9, 2026, 4:10 PM EDT
ALX Oncology Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 279 | 61 | 88 | 742 | 459 | 870 | |
| Market Cap Growth | 373.06% | -30.44% | -88.13% | 61.50% | -47.23% | -74.66% | |
| Enterprise Value | 234 | 16 | -43 | 567 | 181 | 488 | |
| Last Close Price | 2.13 | 1.13 | 1.67 | 14.89 | 11.27 | 21.49 | |
| PB Ratio | 2.55 | 1.37 | 0.78 | 3.91 | 1.74 | 2.40 | |
| P/TBV Ratio | 6.24 | 1.37 | 0.78 | 3.91 | 1.74 | 2.40 | |
| Debt / Equity Ratio | 0.35 | 0.35 | 0.15 | 0.05 | 0.04 | 0.00 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -0.97 | -0.91 | -0.97 | -1.00 | |
| Net Debt / EBITDA Ratio | 0.45 | 0.45 | 0.78 | 1.02 | 2.02 | 4.35 | |
| Net Debt / FCF Ratio | - | - | 0.91 | 1.32 | 2.83 | 5.28 | |
| Quick Ratio | - | - | 6.95 | 5.10 | 9.40 | 23.78 | |
| Current Ratio | - | - | 7.26 | 5.24 | 9.57 | 24.00 | |
| Return on Equity (ROE) | -128.39% | -128.39% | -88.91% | -70.97% | -39.42% | -21.05% | |
| Return on Assets (ROA) | - | - | -45.62% | -38.77% | -23.20% | -12.80% | |
| Return on Capital Employed (ROCE) | - | - | -110.20% | -82.40% | -45.80% | -22.90% | |
| Earnings Yield | -36.39% | -165.99% | -153.10% | -21.68% | -26.88% | -9.59% | |
| FCF Yield | - | - | -138.92% | -17.75% | -19.74% | -7.90% | |
| Buyback Yield / Dilution | -2.84% | -2.84% | -21.37% | -5.62% | -0.97% | -118.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.